Neoplasms, Neuroepithelial  >>  Zejula (niraparib)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Zejula (niraparib) / GSK, J&J
NCT01294735: Study of the Safety and Efficacy of MK-4827 Given With Temozolomide in Participants With Advanced Cancer (MK-4827-014 AM1)

Checkmark ASCO 2014
May 2014 - May 2014: ASCO 2014
Completed
1
19
US
MK-4827, Temozolomide
Merck Sharp & Dohme LLC
Recurrence of Solid Tumor, Glioblastoma Multiforme, Melanoma
04/12
05/12

Download Options